| |
Note |
|
|
2008
R million |
|
|
*
2007
R million |
|
Year ended
30 Sept
2007
R million |
| |
|
|
|
|
|
|
|
|
(Audited) |
| Share capital and premium |
|
|
|
92,0 |
|
|
82,3 |
|
90,8 |
| Balance at the beginning of the period |
|
|
|
90,8 |
|
|
76,9 |
|
76,9 |
| Issue of shares |
|
|
|
1,2 |
|
|
5,5 |
|
14,0 |
| Shares cancelled in terms of buy-back of treasury shares – capital portion |
|
|
|
— |
|
|
(0,1) |
|
(0,1) |
| Share-based payment reserve |
|
|
|
656,1 |
|
|
651,5 |
|
649,9 |
| Balance at the beginning of the period |
|
|
|
649,9 |
|
|
40,4 |
|
40,4 |
| Share-based payment expense |
|
|
|
6,2 |
|
|
611,1 |
|
607,4 |
| Contribution by Reunert to employees of joint venture and associate in terms of broad-based scheme |
|
|
|
— |
|
|
— |
|
2,1 |
| Fair value adjustment reserve** |
|
|
|
552,4 |
|
|
— |
|
— |
| Balance at the beginning of the period |
|
|
|
— |
|
|
— |
|
— |
| Arising on fair valuation of financial instruments |
|
|
|
591,7 |
|
|
— |
|
— |
| Deferred taxation on fair value gain |
|
|
|
(39,3) |
|
|
— |
|
— |
| Treasury shares |
10 |
|
|
(276,1) |
|
|
(276,1) |
|
(276,1) |
| Balance at the beginning of the period |
|
|
|
(276,1) |
|
|
(282,0) |
|
(282,0) |
| Shares cancelled in terms of buy-back of treasury shares – capital portion |
|
|
|
— |
|
|
0,1 |
|
0,1 |
| Shares cancelled in terms of buy-back of treasury shares – dividend portion |
|
|
|
— |
|
|
5,8 |
|
5,8 |
| Non-distributable reserves |
|
|
|
2,1 |
|
|
3,7 |
|
7,3 |
| Balance at the beginning of the period – restated* |
|
|
|
7,3 |
|
|
3,7 |
|
3,7 |
| Balance at the beginning of the period – as previously reported |
|
|
|
7,3 |
|
|
104,8 |
|
104,8 |
| Share of associate company’s retained earnings at the beginning of the period transferred to retained earnings |
|
|
|
— |
|
|
(101,1) |
|
(101,1) |
| Transfer from retained earnings – restated* |
|
|
|
— |
|
|
— |
|
— |
| Transfer from retained earnings – as previously reported |
|
|
|
— |
|
|
64,4 |
|
— |
| Transfer from retained earnings reversed |
|
|
|
— |
|
|
(64,4) |
|
— |
| Translation reserve |
|
|
|
(1,3) |
|
|
— |
|
(0,3) |
| Reunert’s share of previously equity-accounted associate’s actuarially
valued surplus of medical aid provision |
|
|
|
— |
|
|
— |
|
3,9 |
| Reunert’s share of previously equity-accounted valued associate’s actuarially valued surplus of medical aid provision transferred from non-distributable reserves *** |
|
|
|
(3,9) |
|
|
— |
|
— |
| Retained earnings |
|
|
|
2 099,2 |
|
|
1 409,9 |
|
1 997,1 |
| Balance at the beginning of the period – restated* |
|
|
|
1 997,1 |
|
|
1 841,9 |
|
1 841,9 |
| Balance at the beginning of the period – as previously reported |
|
|
|
1 997,1 |
|
|
1 740,8 |
|
1 740,8 |
| Share of associate company’s retained earnings at the beginning of the period transferred from non-distributable reserves |
|
|
|
— |
|
|
101,1 |
|
101,1 |
| Profit/(loss) for the period |
|
|
|
526,3 |
|
|
(77,2) |
|
639,3 |
| Transfer to non-distributable reserves – restated* |
|
|
|
— |
|
|
— |
|
— |
| Transfer to non-distributable reserves – as previously reported |
|
|
|
— |
|
|
(64,4) |
|
— |
| Transfer to non-distributable reserves reversed |
|
|
|
— |
|
|
64,4 |
|
— |
| Reunert’s share of previously equity-accounted valued associate’s actuarially valued surplus of medical aid provision transferred from non-distributable reserves *** |
|
|
|
3,9 |
|
|
— |
|
— |
| Cash dividends declared |
|
|
|
(428,1) |
|
|
(354,8) |
|
(478,3) |
| Shares cancelled in terms of buy-back of treasury shares – dividend portion |
|
|
|
— |
|
|
— |
|
(5,8) |
 |
|
|
|
|
|
|
|
|
|
| Equity attributable to equity holders of Reunert Limited |
|
|
|
3 125,7 |
|
|
1 871,3 |
|
2 469,0 |
| Minority interest |
|
|
|
16,3 |
|
|
31,4 |
|
14,4 |
| Balance at the beginning of the period |
|
|
|
14,4 |
|
|
38,2 |
|
38,2 |
| Profit for the period |
|
|
|
2,7 |
|
|
3,1 |
|
7,6 |
| Dividends declared |
|
|
|
(1,8) |
|
|
(4,5) |
|
(4,5) |
| Net movement in minorities |
|
|
|
1,0 |
|
|
(5,4) |
|
(26,9) |
|
|
|
|
|
|
|
|
|
|
| Total equity at the end of the period |
|
|
|
3 142,0 |
|
|
1 902,7 |
|
2 483,4 |
| * |
The March 2007 information has been restated to reflect the change in accounting policy that took place in the prior year
whereby the group’s share of the associate company’s retained earnings were previously transferred to a non-distributable
reserve. |
| ** |
This reserve relates to fair value adjustments on financial assets designated as “available for sale” financial assets in terms
of IAS 39. |
| *** |
Since Reunert’s investment in NSN is no longer equity-accounted (refer to note 7) this reserve has been transferred to retained
earnings. |
|
|
|
